Sign in
Taking people in United StatesNo phase

How social isolation relates to health as people with schizophrenia age

Studies how social isolation affects physical health in adults with schizophrenia and their siblings.

Key facts

Who runs it
Icahn School of Medicine at Mount Sinai
Where
Hartford, United StatesSee the siteAlso in 3 other countries, 3 sites
Trial code
Registry title
Social Isolation and Aging in Schizophrenia
Status
Recruiting
People taking part
650 people, planned
Started
9 Jan 2024
Expected to end
Jul 2027
Type of study
Observational, 2 groups
Record updated
19 February 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 40 to 70 with a schizophrenia-related disorder, and for their siblings without such a disorder. All were in an earlier research study at least 5 years ago.

Age
40 to 70 years
Sex
All sexes
Disease stage
People with schizophrenia or a related disorder (such as schizoaffective or schizophreniform disorder) who are clinically stable. Siblings must have no diagnosis that affects social functioning.
Earlier treatment
No hospital stay in the 3 months before joining and no medication change in the 4 weeks before joining.

Main reasons for not taking part

  • Psychotic disorder caused only by substances
  • Serious head injury (loss of consciousness longer than 1 hour)
  • History of IQ below 70 or developmental disability
  • Cannot understand the spoken language of the country well enough for the tests
  • Siblings: any diagnosis known to affect social functioning, such as severe mood disorder or autism spectrum disorder

The registry criteria, word for word

Show all 15 criteriaShow less

Other criteria

  • Inclusion and exclusion criteria for participants with SZ:
  • DSM-IV or V diagnosis of a SZ related disorder (295.x, 297.1, 298.8, or 298.9; e.g., schizophrenia, schizoaffective disorder, schizophreniform disorder, but not psychotic disorder that is solely substance induced) based on clinical interview
  • Between 40 and 70 years of age at time of study recruitment
  • Participant was enrolled in a previous research study between the ages of 20-55, and this study took place at least 5 years ago
  • Able to understand the spoken language of the participating country sufficiently to comprehend testing procedures
  • No history of serious head injury (i.e., loss of consciousness longer than 1 hour, no neuropsychological sequelae, no cognitive rehabilitation treatment post head injury)
  • No history of IQ < 70, or developmental disability based on chart review
  • Clinically stable (i.e., no inpatient hospitalizations for three months prior to enrollment, no changes in medication in the four weeks prior to enrollment; The inclusion and exclusion criteria for sibling participants in this study will be:
  • No history of any DSM IV/V Axis I or axis II diagnosis that is known to be associated with social functioning (e.g. severe mood disorder, schizoaffective personality disorder, autism spectrum disorder)
  • Between 40 and 70 years of age at time of study recruitment
  • Participant was enrolled in a previous research study between the ages of 20-55, and this study took place at least 5 years ago
  • Able to understand the spoken language of the participating country sufficiently to comprehend testing procedures
  • No history of serious head injury (i.e., loss of consciousness longer than 1 hour, no neuropsychological sequelae, no cognitive rehabilitation treatment post head injury)
  • No history of IQ < 70, or developmental disability based on chart review
  • Clinically stable (i.e., no inpatient hospitalizations for three months prior to enrollment, no changes in medication in the four weeks prior to enrollment

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 40 and 70 years old?

Where in United States

Also in 3 other countries, 3 sites

  • Olin Neuropsychiatry Research Center, HartfortHartford, United StatesContact: Michael Stevens, PhDTaking people

About the trial

What the trial wants to find out

Individuals diagnosed with schizophrenia and related psychotic disorders (SZ) exhibit a markedly elevated risk of premature mortality, with a 10-20-year shorter lifespan relative to the general population. Increased mortality rates in SZ are largely attributable to the early manifestation of medical conditions that normally occur later in life, a process known as 'accelerated aging'. While unhealthy lifestyle behaviors, such as smoking and unhealthy diet, account, in part, for accelerated aging in SZ, the excess of physical comorbidities cannot be solely attributed to these factors. Remarkably, the direct adverse health effects of key clinical characteristics of SZ have rarely been considered. In the general population, the absence of social contact is known to pose enormous challenges for physical health, especially at older ages. Given that social isolation is a persistent and disabling feature of SZ, it is possible that this behavior may contribute to the premature manifestation of health conditions in SZ. Building on rich pilot data pointing to significant associations between social isolation and long-term perceived health in SZ, the overarching goal is to test whether and how social isolation contributes to the health challenges of individuals with SZ as they age. With participants from Europe (EU-GEI) and the US (Olin Neuropsychiatry Research Center), the researchers will create a longitudinal database of 650 participants, including 500 individuals with SZ, and 150 of their unaffected siblings. The researchers will apply an accelerated longitudinal design by reassessing and by examining medical records of research participants who were first evaluated between the ages of 20-55 and are now 40-70 years of age, a period when many medical conditions and health problems tend to manifest. The researchers will determine the age-related association between social isolation and adverse health outcomes in SZ, test for familiality, directionality, and factors moderating this association, and determine the extent to which the COVID-19 pandemic and the resulting imposed lockdowns impacted health in SZ. The researchers will consider generalizability across countries, sexes, and race/ethnicities. The rationale for the proposed research is that in order to facilitate much-needed targeted therapies to prevent early mortality in SZ, the researchers need to better understand factors that contribute to the excess of medical comorbidities in SZ. The central hypothesis is that social isolation, a common and persistent characteristic of SZ, contributes to the excess of physical comorbidities in SZ. To meet the overall goal, the following aims are: (1) Determine the association between social isolation and adverse health outcomes in SZ; (2) Test for the directionality, and moderating factors, of the association between social isolation and health outcomes in SZ, and; (3) Examine whether the COVID-19 pandemic modified associations between social isolation and health outcome in SZ. This study will be the first to comprehensively examine the health impact of social isolation in SZ. The project may show that in SZ socialization in midlife can reduce the risk for poor health outcomes and ultimately facilitate much-needed preventive targeted therapies to reduce early-age mortality in SZ

The 2 groups in the trial

  • Individuals with SZ

    Individuals with a schizophrenia-related diagnosis

  • Unaffected first-degree relatives

    Unaffected first-degree relatives of individuals with a schizophrenia-related diagnosis

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Impact of Social Isolation on Aging Health in Schizophrenia
Plain-language title
How social isolation relates to health as people with schizophrenia ageGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 13 November 2026.
Fit questions
Built from NCT07419321, who can take part
Publications
Record updated
19 February 2026